Author: Salminen, Antero
Title: Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions Cord-id: 57hnvebo Document date: 2021_8_25
ID: 57hnvebo
Snippet: The functional competence of the immune system gradually declines with aging, a process called immunosenescence. The age-related remodelling of the immune system affects both adaptive and innate immunity. In particular, a chronic low-grade inflammation, termed inflammaging, is associated with the aging process. Immunosenescence not only is present in inflammaging state, but it also occurs in several pathological conditions in conjunction with chronic inflammation. It is known that persistent inf
Document: The functional competence of the immune system gradually declines with aging, a process called immunosenescence. The age-related remodelling of the immune system affects both adaptive and innate immunity. In particular, a chronic low-grade inflammation, termed inflammaging, is associated with the aging process. Immunosenescence not only is present in inflammaging state, but it also occurs in several pathological conditions in conjunction with chronic inflammation. It is known that persistent inflammation stimulates a counteracting compensatory immunosuppression intended to protect host tissues. Inflammatory mediators enhance myelopoiesis and induce the generation of immature myeloid-derived suppressor cells (MDSC) which in mutual cooperation stimulates the immunosuppressive network. Immunosuppressive cells, especially MDSCs, regulatory T cells (Treg), and M2 macrophages produce immunosuppressive factors, e.g., TGF-β, IL-10, ROS, arginase-1 (ARG1), and indoleamine 2,3-dioxygenase (IDO), which suppress the functions of CD4/CD8T and B cells as well as macrophages, natural killer (NK) cells, and dendritic cells. The immunosuppressive armament (i) inhibits the development and proliferation of immune cells, (ii) decreases the cytotoxic activity of CD8T and NK cells, (iii) prevents antigen presentation and antibody production, and (iv) suppresses responsiveness to inflammatory mediators. These phenotypes are the hallmarks of immunosenescence. Immunosuppressive factors are able to control the chromatin landscape, and thus, it seems that the immunosenescence state is epigenetically regulated.
Search related documents:
Co phrase search for related documents- adaptive immunity and local inflammation: 1, 2, 3, 4, 5
- adaptive immunity and local systemic: 1, 2, 3, 4, 5, 6, 7, 8
- adaptive immunity and low grade inflammation: 1, 2, 3, 4, 5, 6
- adaptive immunity and low grade inflammatory state: 1
- adaptive immunity and lps treatment: 1
- adaptive immunity and lung immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- adaptive immunity and lung macrophage: 1
- adaptive immunity and macrophage chemotaxis: 1
- adipose tissue and local inflammation: 1, 2, 3, 4, 5, 6
- adipose tissue and local systemic: 1, 2, 3, 4, 5, 6, 7
- adipose tissue and low cytotoxicity: 1
- adipose tissue and low grade inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- adipose tissue and low grade inflammatory state: 1, 2, 3
- adipose tissue and low macrophage: 1, 2
- adipose tissue and lung immunity: 1
- adipose tissue and lymphocyte subset: 1
- adipose tissue and macrophage dendritic cell: 1, 2
Co phrase search for related documents, hyperlinks ordered by date